Faculty Opinions recommendation of Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.
Keyword(s):
Keyword(s):
Keyword(s):
1999 ◽
Vol 69
(9)
◽
pp. 681-682
◽
Keyword(s):
2007 ◽
Vol 99
(7)
◽
pp. 506-515
◽